These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 28796819)
1. Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma. Diao R; Mu X; Wang T; Li S PLoS One; 2017; 12(8):e0182908. PubMed ID: 28796819 [TBL] [Abstract][Full Text] [Related]
2. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis. Zhu H; Yu J; Zhu H; Guo Y; Feng S World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257 [TBL] [Abstract][Full Text] [Related]
3. Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma. Liu G; Dong C; Wang X; Hou G; Zheng Y; Xu H; Zhan X; Liu L Oncotarget; 2017 Nov; 8(58):98360-98370. PubMed ID: 29228695 [TBL] [Abstract][Full Text] [Related]
4. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796 [TBL] [Abstract][Full Text] [Related]
5. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma. Gong W; Tian M; Qiu H; Yang Z Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of perineural invasion in stages II and III colorectal cancer. Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129 [TBL] [Abstract][Full Text] [Related]
7. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer. Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967 [TBL] [Abstract][Full Text] [Related]
8. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy. Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332 [TBL] [Abstract][Full Text] [Related]
9. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer. Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer. Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432 [TBL] [Abstract][Full Text] [Related]
11. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway. Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879 [TBL] [Abstract][Full Text] [Related]
12. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer. Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222 [TBL] [Abstract][Full Text] [Related]
13. MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Matsuyama T; Ishikawa T; Mogushi K; Yoshida T; Iida S; Uetake H; Mizushima H; Tanaka H; Sugihara K Int J Cancer; 2010 Nov; 127(10):2292-9. PubMed ID: 20162577 [TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis. Ye LC; Ren L; Qiu JJ; Zhu DX; Chen T; Chang WJ; Lv SX; Xu J Tumour Biol; 2015 Nov; 36(11):8747-54. PubMed ID: 26050227 [TBL] [Abstract][Full Text] [Related]
15. Seven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma. Zhang ZL; Zhao LJ; Chai L; Zhou SH; Wang F; Wei Y; Xu YP; Zhao P Sci Rep; 2017 Mar; 7(1):309. PubMed ID: 28331188 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer. Qiu JJ; Yan JB Tumour Biol; 2015 Sep; 36(9):7175-83. PubMed ID: 25894381 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer. Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer. Shen X; Bai Y; Luo B; Zhou X Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer. Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791 [TBL] [Abstract][Full Text] [Related]
20. Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer. Wang R; Du L; Yang X; Jiang X; Duan W; Yan S; Xie Y; Zhu Y; Wang Q; Wang L; Yang Y; Wang C J Cancer Res Clin Oncol; 2016 Nov; 142(11):2291-301. PubMed ID: 27591862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]